WuXi XDC Cayman Inc
2268
Rang în acțiuni
#1886
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Preț acțiune
$8.78
Capitalizare de piață
$11.12B
Schimbare (1 zi)
-9.52%
Schimbare (1 an)
0.57%
Țară
CN
Tranzacționează WuXi XDC Cayman Inc (2268)
Categorie
Healthcare
Raport P/B pentru WuXi XDC Cayman Inc (2268)
Raport P/B la data de October 2026 TTM: 6.53
Conform celor mai recente rapoarte financiare și prețului acțiunilor WuXi XDC Cayman Inc, raportul P/B actual (TTM) este 6.53. La sfârșitul anului 2024, compania avea un P/B de 5.20.
Istoricul raportului P/B pentru WuXi XDC Cayman Inc din 2020 până în 2026
Raport P/B la sfârșitul fiecărui an
| An | Raport P/B | Schimbă |
|---|---|---|
| 2026 (TTM) | 6.53 | -2.87% |
| 2025 | 6.72 | 29.37% |
| 2024 | 5.20 | -10.37% |
| 2023 | 5.80 | -70.54% |
| 2022 | 19.68 | -98.47% |
| 2021 | 1.29K | 1,641.63% |
| 2020 | 73.89 | 0.00% |
Raport P/B pentru companii similare sau competitoare
| Companie | Raport P/B | Diferență raport P/B | Țara |
|---|---|---|---|
| 4.7411 | -27.36% |
US
|
|
| 3.0143 | -53.82% |
US
|
|
| 31.051 | 375.74% |
US
|
|
| 4.9326 | -24.43% |
CN
|
|
| 6.8081 | 4.31% |
US
|
